Plalab Placenta Peeling Gel
Peeling (Peeling)
Plalab Placenta Peeling
FDA Label NDC 70326-101
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Renocell Co., Ltd for the product Plalab Placenta Peeling (NDC 70326-101). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding plalab placenta peeling gel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
* Please review the disclaimer below.
